African Civil Society Groups Challenge Gilead’s Lenacapavir Prodrug Patent Application at ARIPO - KELIN Kenya

African Civil Society Groups Challenge Gilead’s Lenacapavir Prodrug Patent Application at ARIPO - KELIN Kenya

Public health and human rights organisations from Kenya, Uganda and Malawi filed a third-party observation with the African Regional Intellectual Property Organization (ARIPO) on August 31, challenging all 43 claims in a Gilead Sciences patent application covering prodrug compounds related to the HIV medicine lenacapavir. ARIPO, a Harare-based intergovernmental intellectual property organisation grants and administers...